Companies Dominating the Hypertension Drugs Landscape
- Janssen Global Services, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Atnahs Pharma UK Limited
- Sanofi US Services Inc.
- Pfizer Laboratories Div Pfizer Inc
- Merck & Co., Inc.
- Abbott Laboratories
- Daiichi Sankyo Company, Limited
- Novartis Pharmaceuticals Corporation
- Boehringer Ingelheim group
- Lupin Ltd.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Hypertension Drugs Market in 2025 is estimated at USD 22.64 billion.
The global market size was worth over USD 21.85 billion in 2024 and is poised to grow at a CAGR of around 4.5%, reaching USD 38.72 billion revenue by 2037.
North America is anticipated to attain USD 11.62 billion by 2037, attributed to presence of leading market players manufacturing hypertension drugs.
The major players in the market include Janssen Global Services, LLC, Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, Novartis Pharmaceuticals Corporation, Boehringer Ingelheim group, Lupin Ltd.
